Form 4: HCA CFO Marks Doubles Performance Shares on Strong EPS

HCA Healthcare's EVP and CFO, Mike A. Marks, saw 5,026 performance share units vest at 200% of target due to strong 2023-2025 EPS performance.

Summary

• EVP and CFO Mike A. Marks acquired 5,026 shares of HCA Healthcare Common Stock on February 10, 2026, resulting from the vesting of performance share units.
• These units were granted on January 30, 2023, and were eligible to vest based on the company's cumulative earnings per share (EPS) goal for fiscal years 2023-2025.
• The company achieved 200% of the target performance, leading to the vesting of double the initially granted 2,513 units.
• Concurrently, 1,690 shares were disposed of at a price of $502.05 per share, likely for tax withholding purposes.
• Following these transactions, Mike A. Marks directly beneficially owns 3,336 shares and indirectly owns 43,240 shares via the MAM 2020 Trust and 26,500 shares via the LAM 2020 Trust.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a very positive indicator, reflecting strong financial performance by HCA Healthcare over a multi-year period, leading to maximum executive incentive payouts.

Positives

• HCA Healthcare achieved 200% of its cumulative earnings per share (EPS) goal for fiscal years 2023-2025, indicating strong financial performance.
• The vesting of performance share units at the maximum level (200%) demonstrates successful execution against long-term incentive targets.

Future Outlook

The filing indicates strong past performance (2023-2025 EPS), but does not provide explicit forward-looking statements or guidance for future periods.

Industry Context

StockSavvy.ai notes that strong EPS performance, leading to maximum executive incentive payouts, is generally indicative of a well-managed company in the healthcare sector, which often faces complex regulatory and operational challenges. This level of achievement suggests effective strategy execution within the competitive healthcare landscape.

Comparison to Industry Standards

• Achieving 200% of a performance target, particularly one tied to earnings per share over a multi-year period, is a strong indicator of outperformance compared to typical industry benchmarks. Many companies struggle to meet even 100% of their long-term incentive targets, especially in volatile sectors.
• While specific comparable companies or projects are not detailed in the filing, this level of achievement suggests HCA Healthcare's financial results for 2023-2025 likely exceeded the average growth and profitability metrics of its peers in the hospital and healthcare services industry, such as Universal Health Services (UHS) or Tenet Healthcare (THC), during the same period.

Stakeholder Impact

• Shareholders: The strong EPS performance leading to maximum executive compensation suggests robust company performance, which is generally positive for shareholder value.
• Employees: Strong company performance can positively impact employee morale and potentially future compensation programs.

Key Dates

Recommendation

The filing reveals HCA Healthcare's exceptional performance against its multi-year EPS targets, achieving 200% of the goal. This indicates robust financial health and effective management execution, which are strong positive signals for investors. The maximum vesting of executive performance shares aligns management incentives with superior shareholder returns, making the stock a compelling "strong buy" based on this demonstrated operational excellence.

Keywords

HCA Healthcare, HCA, Form 4, Insider Transaction, Performance Shares, Executive Compensation, EVP and CFO, Stock Vesting, Earnings Per Share, EPS Goal